Stocks›Healthcare›LUCYW

LUCYW

INNOVATIVE EYEWEAR, INC.

NasdaqResearch view

Healthcare · Ophthalmic Goods · SEC EDGAR FY 2025-12-31

Price history

Chart: TradingView’s own feed · page prices: 1D EOD

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Income$-7.6M

Sales$2.7M

Book/sh$1.05

Cash/sh$0.76

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio7.36

Current Ratio9.03

Debt/Eq—

EPS (ttm)$-1.90

EPS this Y63.4%

EPS past 3/5Y—

Sales past 3/5Y59.2%

EPS Y/Y TTM63.4%

Sales Y/Y TTM62.6%

Shs Outstand8.61M

ROA-74.9%

ROE-83.7%

ROIC—

Gross Margin21.3%

Oper. Margin—

Profit Margin-285.2%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue & Earnings — fiscal year

$690,670

2021

$659,788

2022

$1.2M

2023

$1.6M

2024

$2.7M

2025

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$690,670	$659,788	$1.2M	$1.6M	$2.7M
Gross Profit	$148,254	$-56,289	$-119,329	$215,190	$567,451
Operating Income	—	—	—	—	—
Net Income	$-3.2M	$-5.7M	$-6.7M	$-7.8M	$-7.6M
Diluted EPS	—	$-0.87	$-10.87	$-5.19	$-1.90
Operating Cash Flow	$-1.2M	$-3.2M	$-5.8M	$-6.7M	$-7.3M
Free Cash Flow	$-1.2M	$-3.3M	$-5.8M	$-6.8M	$-7.3M